Table 1.
Baseline characteristics of patients in the control and adaptive servo‐ventilation (ASV) arms
| Total population | Control group | ASV group | P‐value | |
|---|---|---|---|---|
| Subject (n) | 56 | 29 | 27 | |
| Age (years) | 64.1 ± 9.8 | 64.5 ± 9.5 | 63.6 ± 10.2 | 0.747 |
| Males (n) | 51 (91%) | 26 (90%) | 25 (93%) | 0.393 |
| BMI (kg/m2) | 30.6 ± 4.8 | 31.7 ± 5.0 | 29.4 ± 4.3 | 0.071 |
| Overweight | 23 (41.7%) | 12 (41%) | 11 (41%) | 0.961 |
| Obese | 28 (50%) | 17 (59%) | 11 (41%) | 0.178 |
| FEV1/FVC ratio | 0.774 ± 0.079 | 0.773 ± 0.082 | 0.776 ± 0.077 | 0.884 |
| Medical history | ||||
| Afib | 16 (28.6%) | 11 (38%) | 5 (19%) | 0.099 |
| MI | 29 (51.8%) | 15 (52%) | 14 (52%) | 0.782 |
| Angina | 10 (17.9%) | 4 (14%) | 6 (21%) | 0.822 |
| HT | 27 (48.2%) | 14 (48%) | 15 (48%) | 0.796 |
| OSA | 30 (53.6%) | 16 (55%) | 14 (52%) | 0.578 |
Afib, atrial fibrillation; BMI, body mass index; FEV1/FVC ratio, the ratio of the forced expiratory volume in the first second to the forced vital capacity of the lungs; HT, hypertension; MI, myocardial infarction, OSA, obstructive sleep apnoea.
P‐values represent the results of the two‐tailed t‐test and the χ 2 test.